» Articles » PMID: 9986871

Cryptococcus Neoformans Var. Grubii: Separate Varietal Status for Cryptococcus Neoformans Serotype A Isolates

Overview
Specialty Microbiology
Date 1999 Feb 13
PMID 9986871
Citations 115
Authors
Affiliations
Soon will be listed here.
Abstract

Cryptococcus neoformans var. neoformans presently includes isolates which have been determined by the immunologic reactivity of their capsular polysaccharides to be serotype A and those which have been determined to be serotype D. However, recent analyses of the URA5 sequences and DNA fingerprinting patterns suggest significant genetic differences between the two serotypes. Therefore, we propose to recognize these genotypic distinctions, as well as previously reported phenotypic differences, by restricting C. neoformans var. neoformans to isolates which are serotype D and describing a new variety, C. neoformans var. grubii, for serotype A isolates.

Citing Articles

Evolutionary origin and population diversity of a cryptic hybrid pathogen.

Steenwyk J, Knowles S, Bastos R, Balamurugan C, Rinker D, Mead M Nat Commun. 2024; 15(1):8412.

PMID: 39333551 PMC: 11436853. DOI: 10.1038/s41467-024-52639-1.


Quantitative MRI of a Cerebral Cryptococcoma Mouse Model for In Vivo Distinction between Different Cryptococcal Molecular Types.

Musetta L, Helsper S, Roosen L, Maes D, Croitor Sava A, Vanherp L J Fungi (Basel). 2024; 10(8).

PMID: 39194918 PMC: 11355240. DOI: 10.3390/jof10080593.


Evolutionary origin, population diversity, and diagnostics for a cryptic hybrid pathogen.

Steenwyk J, Knowles S, Bastos R, Balamurugan C, Rinker D, Mead M bioRxiv. 2023; .

PMID: 37461539 PMC: 10350022. DOI: 10.1101/2023.07.03.547508.


Exploring CYP51 and Its Cognate Reductase as a Drug Target.

Ruma Y, Keniya M, Monk B J Fungi (Basel). 2022; 8(12).

PMID: 36547589 PMC: 9785471. DOI: 10.3390/jof8121256.


The Cryptococcus gattii species complex: Unique pathogenic yeasts with understudied virulence mechanisms.

Saidykhan L, Onyishi C, May R PLoS Negl Trop Dis. 2022; 16(12):e0010916.

PMID: 36520688 PMC: 9754292. DOI: 10.1371/journal.pntd.0010916.


References
1.
Spitzer E, Spitzer S . Use of a dispersed repetitive DNA element to distinguish clinical isolates of Cryptococcus neoformans. J Clin Microbiol. 1992; 30(5):1094-7. PMC: 265231. DOI: 10.1128/jcm.30.5.1094-1097.1992. View

2.
Evans E . The antigenic composition of Cryptococcus neoformans. I. A serologic classification by means of the capsular and agglutination reactions. J Immunol. 1950; 64(5):423-30. View

3.
Kwon-Chung K . The discovery of creatinine assimilation in Cryptococcus neoformans, and subsequent work on the characterization of the two varieties of C. neoformans. Zentralbl Bakteriol. 1991; 275(3):390-3. DOI: 10.1016/s0934-8840(11)80305-1. View

4.
Bennett J, Kwon-Chung K, Howard D . Epidemiologic differences among serotypes of Cryptococcus neoformans. Am J Epidemiol. 1977; 105(6):582-6. DOI: 10.1093/oxfordjournals.aje.a112423. View

5.
Dufait R, Velho R, De Vroey C . Rapid identification of the two varieties of Cryptococcus neoformans by D-proline assimilation. Mykosen. 1987; 30(10):483. View